Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Barton

Showing results (171-180 of 296) with videos related to

Pageof 30
Sort By:
Human Genetics|September 21, 2010
Rare variation at the TNFAIP3 locus and susceptibility to rheumatoid arthritisJohn Bowes, Robert Lawrence, Stephen Eyre, et al.
Annals of the Rheumatic Diseases|August 25, 2009
Dissection of the FCGR3A association with RA: increased association in men and with autoantibody positive diseaseJames I Robinson, Jennifer H Barrett, John C Taylor, et al.
Rheumatology (Oxford, England)|June 30, 2023
A proteomics study of rheumatoid arthritis patients on etanercept identifies putative biomarkers associated with clinical outcome measuresStephanie F Ling, Chuan Fu Yap, Nisha Nair, et al.
Lancet (London, England)|August 28, 2015
Clinical utility of random anti-tumour necrosis factor drug testing and measurement of anti-drug antibodies on long-term treatment response in rheumatoid arthritisMeghna Jani, Hector Chinoy, Richard B Warren, et al.
Plos One|September 17, 2013
Lack of association of variants previously associated with anti-TNF medication response in rheumatoid arthritis patients: results from a homogeneous Greek populationMaria I Zervou, Efsevia Myrthianou, Irene Flouri, et al.
The Pharmacogenomics Journal|September 1, 2018
Genome-wide association study of response to tumour necrosis factor inhibitor therapy in rheumatoid arthritisJonathan Massey, Darren Plant, Kimme Hyrich, et al.
Annals of the Rheumatic Diseases|October 5, 2013
A weighted genetic risk score using all known susceptibility variants to estimate rheumatoid arthritis riskAnnie Yarwood, Buhm Han, Soumya Raychaudhuri, et al.
Rheumatology (Oxford, England)|June 2, 2023
Socioeconomic deprivation is associated with reduced response and lower treatment persistence with TNF inhibitors in rheumatoid arthritisSizheng Steven Zhao, Kira Rogers, Lianne Kearsley-Fleet, et al.
Annals of the Rheumatic Diseases|November 12, 2010
Study of the common genetic background for rheumatoid arthritis and systemic lupus erythematosusGisela Orozco, Steve Eyre, Anne Hinks, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 1, 2020
Latent Class Trajectory Modeling of 2-Component Disease Activity Score in 28 Joints Identifies Multiple Rheumatoid Arthritis Phenotypes of Response to Biologic Disease-Modifying Antirheumatic DrugsArianna Dagliati, Darren Plant, Nisha Nair, et al.
Pageof 30

Showing results (171-180 of 296) with videos related to

Sort By:
Pageof 30
Human Genetics|September 21, 2010
Rare variation at the TNFAIP3 locus and susceptibility to rheumatoid arthritisJohn Bowes, Robert Lawrence, Stephen Eyre, et al.
Annals of the Rheumatic Diseases|August 25, 2009
Dissection of the FCGR3A association with RA: increased association in men and with autoantibody positive diseaseJames I Robinson, Jennifer H Barrett, John C Taylor, et al.
Rheumatology (Oxford, England)|June 30, 2023
A proteomics study of rheumatoid arthritis patients on etanercept identifies putative biomarkers associated with clinical outcome measuresStephanie F Ling, Chuan Fu Yap, Nisha Nair, et al.
Lancet (London, England)|August 28, 2015
Clinical utility of random anti-tumour necrosis factor drug testing and measurement of anti-drug antibodies on long-term treatment response in rheumatoid arthritisMeghna Jani, Hector Chinoy, Richard B Warren, et al.
Plos One|September 17, 2013
Lack of association of variants previously associated with anti-TNF medication response in rheumatoid arthritis patients: results from a homogeneous Greek populationMaria I Zervou, Efsevia Myrthianou, Irene Flouri, et al.
The Pharmacogenomics Journal|September 1, 2018
Genome-wide association study of response to tumour necrosis factor inhibitor therapy in rheumatoid arthritisJonathan Massey, Darren Plant, Kimme Hyrich, et al.
Annals of the Rheumatic Diseases|October 5, 2013
A weighted genetic risk score using all known susceptibility variants to estimate rheumatoid arthritis riskAnnie Yarwood, Buhm Han, Soumya Raychaudhuri, et al.
Rheumatology (Oxford, England)|June 2, 2023
Socioeconomic deprivation is associated with reduced response and lower treatment persistence with TNF inhibitors in rheumatoid arthritisSizheng Steven Zhao, Kira Rogers, Lianne Kearsley-Fleet, et al.
Annals of the Rheumatic Diseases|November 12, 2010
Study of the common genetic background for rheumatoid arthritis and systemic lupus erythematosusGisela Orozco, Steve Eyre, Anne Hinks, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 1, 2020
Latent Class Trajectory Modeling of 2-Component Disease Activity Score in 28 Joints Identifies Multiple Rheumatoid Arthritis Phenotypes of Response to Biologic Disease-Modifying Antirheumatic DrugsArianna Dagliati, Darren Plant, Nisha Nair, et al.
Pageof 30